Search

everythinglearnresearchcommunity

for

Search:↓

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

MR antagonists may improve skin health and wound healing, especially in aging.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Topical cyclosporin-A is recommended for severe alopecia areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

The hydrogel speeds up healing of normal and MRSA-infected wounds.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Convulsofin effectively treats primary epilepsy but has some side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.